首页> 外文OA文献 >The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

【2h】

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

机译：不包括稀有疾病系统评论中的非扫描研究的影响：“荟萃分析的例子评估粘性多甲患者酶替代疗法的疗效和安全性”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Miguel Sampayo-Cordero; Bernat Miguel-Huguet; Andrea Malfettone; José Manuel Pérez-García; Antonio Llombart-Cussac; Javier Cortés; Almudena Pardo; Jordi Pérez-López;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis” [J] . Sampayo-Cordero Miguel, Miguel-Huguet Bernat, Malfettone Andrea, Frontiers in Molecular Biosciences . 2021,第a期

机译：不包括罕见疾病的系统评论中的非扫描研究的影响：“荟萃分析的例子评估粘性蛋白患者酶替代治疗的疗效和安全性”
2. Agreement between the results of meta-analyses from case reports and from clinical studies regarding the efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age: An example of case reports meta-analyses as an useful tool for evidence-based medicine in rare diseases [J] . Sampayo-Cordero Miguel, Miguel-Huguet Bernat, Pardo-Mateos Almudena, Molecular genetics and metabolism . 2018,第2期

机译：从病例报告和临床研究之间的临床研究与临床研究之间的达成协议，关于成人年龄的粘性酶蛋白患者的霉菌酶治疗患者的疗效：案件报告的例子作为证据的有用工具基于罕见疾病的药物
3. Efficacy of Idursulfase therapy in patients with Mucopolysaccharidosis type II who initiated enzyme replacement therapy in adult age. A systematic review of the literature [J] . J. Pérez-López, M. Moltó-Abad, C. Mu?oz-Delgado, Molecular genetics and metabolism . 2018,第3期

机译：IDUSULFASE治疗在成人年龄发起酶替代疗法的粘性多种患者患者中的疗效。系统审查文献
4. Transcranial near infrared laser therapy (NILT) to treat acute ischemic stroke: a review of efficacy, safety and possible mechanism of action derived from rabbit embolic stroke studies [C] . Paul A. Lapchak, Jackson Streeter, Luis De Taboada Mechanisms for low-light therapy V . 2010

机译：经颅近红外激光治疗急性缺血性中风：兔栓塞性中风研究的疗效，安全性和可能的作用机制综述
5. The Efficacy of Extracorporeal Shock Wave Therapy in Comparison to Low-Level Laser Therapy for Decreasing Pain and Symptom Severity and Increasing Functional Status in Adult Patients with Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis [D] . Seely, Andrew. 2021

机译：体外冲击波治疗与低水平激光治疗对脑隧道综合征的成人患者疼痛和症状严重程度及函数状况的疗效：系统评价与荟萃分析
6. The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis [O] . Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Andrea Malfettone, 2021

机译：不包括稀有疾病系统评论中的非扫描研究的影响：荟萃分析的例子评估粘性多甲患者酶替代疗法的疗效和安全性
7. Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type II (MPS-II). A new tool for evidence-based medicine in rare diseases [O] . Miguel Sampayo-Cordero, Bernat Miguel-Huguet, Almudena Pardo-Mateos, 2019

机译：从案例报告和临床研究的核心分析结果之间的协议，关于粘性多甲类患者II型（MPS-II）的IDUSULFASE治疗的疗效和安全性。稀有疾病中循证医学的新工具

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

著录项

引文网络

相似文献

相关主题

期刊订阅